miRNAの世界市場（～2020）...市場調査レポートについてご紹介

1. Analyst View
2. Research Methodology
3. miRNA – An Introduction
4. miRNA Techniques
4.1 miRNA Purification
4.2 miRNA Labeling
4.3 miRNA Linear Amplification
4.4 miRNA Microarrays
4.5 miRNA qRT-PCR
4.6 miRNA Inhibition
4.7 miRNA Transfection
5. Industry Overview
5.1 Market Drivers
5.1.1 Growing Focus on Developing of miRNA-based Diagnostic Biomarkers
5.1.2 Technological Advancements
5.1.3 Rise in miRNA-based Researches
5.1.4 Increasing Prevalence of Chronic Diseases
5.1.5 Rising Investments in miRNA Market
5.2 Market Opportunities
5.2.1 Increasing miRNA-based Research in Cardiovascular Biology and Disease
5.2.2 Therapeutics Application Offers Significant Growth Opportunity
5.3 Market Challenges
5.3.1 High Cost of developing miRNA-based Tools
5.3.2 Technological Challenges in Developing miRNA-based Therapeutics
5.4 Market Trends
5.4.1 Increasing Strategic Alliances in the Market
5.4.2 Next Generation Sequencing: Gaining Momentum
6. Global miRNA Market Outlook to 2020
6.1 miRNA Tools and Services Market
7. Global miRNA Market by Applications
7.1 Research
7.2 Diagnostics
7.3 Drug Development
8. Global miRNA Market by End User
8.1 Research Labs and Institutes
8.2 Biotechnology Industry
8.3 Hospitals and Diagnostic Centers
9. Global miRNA Market by Geography
9.1 The Americas
9.2 Europe
9.3 Asia Pacific (APAC)
10. Global miRNA Market, by Disease
10.1 Introduction
10.2 Cancer
10.3 Neurological Diseases
10.4 Cardiovascular Diseases
10.5 Hepatic Diseases
10.6 Other Diseases
11. Portfolio of miRNA Pathway Drugs Candidates
12. Key Players
12.1 QIAGEN
12.2 Sigma-Aldrich Corporation (A Subsidiary of Merck KGaA)
12.3 Thermo Fisher Scientific, Inc.
12.4 Agilent Technologies Inc.
12.5 Affymetrix
12.6 Integrated DNA Technologies
12.7 Exiqon
12.8 Mirus Bio LLC
12.9 Wako Pure Chemical Industries
12.10 Rosetta Genomics Ltd.

List of Figures

Figure 5-1: Workflow of a miRNA Next-Generation Sequencing Experiment
Figure 6-1: Global – miRNA Market (Million US$), 2014-2020
Figure 6-2: Global – miRNA Tools Market (Million US$), 2014-2020
Figure 6-3: Global – miRNA Services Market (Million US$), 2014-2020
Figure 7-1: Global – miRNA Market by Applications (%), 2014
Figure 7-2: Number of miRNAs in the miRBase Database, (2002–2014)
Figure 7-3: Number of Registered miRNAs for Various Types of Cancers, (2015)
Figure 8-1: Global — miRNA Research Labs & Institutes Market (Million US$), 2014-2020
Figure 8-2: Global – miRNA Biotechnology Industry Market (Million US$), 2014–2020
Figure 8-3: Global – miRNA Hospitals & Diagnostic Center Market (Million US$), 2014-2020
Figure 9-1: The Americas – miRNA Market (Million US$), 2014-2020
Figure 9-2: The Americas – Ongoing miRNA Research by Country (%), 2015
Figure 9-3: The Americas – Ongoing miRNA Research by Disease (%), 2015
Figure 9-4: Europe – miRNA Market (Million US$), 2014-2020
Figure 9-5: Europe – Ongoing miRNA Research by Country (%), 2015
Figure 9-6: Europe – Ongoing miRNA Research by Disease (%), 2015
Figure 9-7: Asia Pacific – miRNA Market (Million US$), 2014-2020
Figure 9-8: Asia Pacific – Ongoing miRNA Research by Country (%), 2015
Figure 9-9: Asia Pacific – Ongoing miRNA Research by Disease (%), 2015
Figure 10-1: Global – miRNA Market by Application (%), 2014
Figure 10-2: Global – miRNA Cancer Market (Million US$), 2014-2020
Figure 10-3: Global – miRNA Neurological Diseases Market (Million US$), 2014-2020
Figure 10-4: Global – miRNA Cardiovascular Diseases Market (Million US$), 2014-2020
Figure 10-5: Global – miRNA Hepatic Diseases Market (Million US$), 2014-2020
Figure 10-6: Global – miRNA Other Diseases Market (Million US$), 2014-2020
Figure 11-1: Major miRNA Clinical Candidates

List of Tables:

Table 4-1: miRNA Purification Products by Supplier
Table 4-2: miRNA Labeling Products by Supplier
Table 4-3: miRNA Linear Amplification Products by Supplier
Table 4-4: miRNA Microarray Products by Supplier
Table 4-5: miRNA qRT-PCR Products by Supplier
Table 4-6: miRNA Inhibition Products by Supplier
Table 4-7: miRNA Transfection Products by Supplier
Table 5-1: Potential miRNAs for Therapeutic Application
Table 9-1: The Americas – miRNA Research (2005-September, 2015)
Table 9-2: Europe – miRNA Research (2005-September, 2015)
Table 9-3: Asia Pacific – miRNA Research (2005-September, 2015)
Table 10-1: miRNAs Associated with Common Human Diseases
Table 10-2: miRNAs Associated with Cancer
Table 10-3: miRNAs Associated with Cardiovascular Disorders
Table 10-4: miRNAs Associated with Hepatitis
Table 11-1: Major Players in miRNA Diagnostics & Therapeutics Applications
Table 12-1: Qiagen – miRNA Associated Product Line
Table 12-2: Sigma Aldrich – miRNA Associated Product Line
Table 12-3: Thermo Fisher – miRNA Associated Product Line
Table 12-4: Agilent – miRNA Associated Product Line
Table 12-5: Affymetrix – miRNA Associated Product Line
Table 12-6: IDT – miRNA Associated Product Line
Table 12-7: Exiqon – miRNA Associated Product Line
Table 12-8: Mirus Bio – miRNA Associated Product Line
Table 12-9: Wako – miRNA Associated Product Line
Table 12-10 Rosetta Genomics- miRNA Associated Product Line